Discern Health partner Tom Valuck, MD, JD, and Vice President Russ Montgomery, PhD, MHS, published a Viewpoint article in the December 2018 edition of the Journal of Clinical Pathways titled “Quality Measurement as a Tool for a Patient-Centered Approach to Assessing Value.” In the article, they outline how quality measures can be a tool for ensuring patient voice is included in assessments of the value of medical technologies.
Drs. Valuck and Montgomery describe how quality measurement can be used to promote wider use of shared decision making, which is a process through which patients and their clinicians review clinical evidence, discuss patient preferences for care, and make informed care decisions. As shared decision making enters wider use, it may be possible to aggregate patient preferences for certain conditions to better understand preference at a population level and consider these preferences when assessing the value of a particular therapy.
“Shared decision making is emerging as one of the foundations of providing high-quality care. Quality measures can be used to establish it as the standard of care,” said Dr. Valuck.
Drs. Valuck and Montgomery were asked to draft their article in response to an article titled “Personalized Medicine in a World of Value Frameworks,” written by Robert W. DuBois, MD, PhD. Dr. DuBois is the chief science officer and executive vice president of the National Pharmaceutical Council (NPC). NPC is a long-standing Discern client.
After publication of the article, Dr. Valuck was invited and agreed to serve on the journal’s Editorial Advisory Committee.